Patient testing is underway for a new therapy for age-related macular degeneration (AMD) developed by the John A. Moran Eye Center’s Sharon Eccles Steele Center for Translational Medicine (SCTM).
A new, $1.9 million National Eye Institute (NEI) grant will allow John A. Moran Eye Center scientists to answer a fundamental question about the eye’s response to age-related macular degeneration...
You might compare most researchers to a scalpel, honed for a specific type of work through years of training. But the newest scientist at the John A. Moran Eye Center...
